Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC

Kentaro Tanaka, Hibiki Udagawa, Hiroaki Akamatsu, Masayuki Takeda, Shintaro Kanda, Ikuko Yasuda, Sumiko Okubo, Shekman Wong, Charity Scripture, Tomohide Tamura, Isamu Okamoto

研究成果: Contribution to journalArticle査読

本文言語英語
ページ(範囲)vii57
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータス出版済み - 10 1 2018

All Science Journal Classification (ASJC) codes

  • 血液学
  • 腫瘍学

引用スタイル